Dendrimers for gene delivery--a potential approach for ocular therapy?

Objectives: A vast number of blinding diseases have genetic aetiologies and may be treated by molecular based therapies such as antisense oligonucleotides or short interfering RNA. However, treatment success of ocular gene therapy is highly dependent on efficient delivery of such molecules.

Key Findings: The majority of clinical studies for ocular gene therapy utilize viral vectors.